Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

USA imposed sanctions against Surgutneftegaz

1/10/25 SNGS

Vostok Oil fell under US sanctions

1/10/25 ROSN

Lukoil may receive about $ 4.3 billion for the sale of its assets in Bulgaria

1/10/25 LKOH

Republika Srpska is committed to long-term relations with Gazprom

1/10/25 GAZP

Sovcombank prepares additional issue

1/10/25 SVCB

Cherkizovo poultry farm buildings on fire in Kursk region

1/9/25 GCHE

VTB completes rebranding of Otkritie branches

1/9/25 VTBR

Shareholders of Perm Energy Supply Company approved dividends

1/9/25 PMSB

Shareholders of Zaymer approved dividends

1/9/25 ZAYM

Inter RAO acquired Mezhregionenergoservice

1/9/25 IRAO